The Flowr Corporation announced that it has entered into a supply agreement with Focus Medical Herbs Ltd. (“Focus Medical”), a company with which IM Cannabis Corp. has an exclusive commercial agreement within Israel. Pursuant to the terms of the Supply Agreement, a wholly-owned subsidiary of Flowr has agreed to export up to five hundred kilograms of premium dry flower cannabis in bulk form into Israel. The Supply Agreement represents the Company’s first significant international distribution agreement and first export opportunity into Israel. The Israeli medical cannabis market was characterized by strong year-over-year growth in 2020. According to Prohibition Partners, active patients grew by approximately 17% from 2019 to 2020, reaching over 70,000 patients, leading to imports into Israel of over 7 tonnes by July 2020.

Sean Hocking, Cannabis Law Report, 06/07/2021 14:35:00

Open article: